| 9:00 | Welcome |
| 9:00 – 10:20 | Diagnostics/Clinic/Imaging |
|
„The algorithm is seeing you now”-Systematic approach to exophthalmos and update on automated diagnosis making U. Schaudig |
|
|
Ophthalmology meets Radiology: Common language or Babylon U. Müller-Lisse |
|
|
Hertel-Exophthalmometry and beyond A. Klingenstein |
|
|
MRI-Imaging of the orbit: T1, T2 and what else? U. Müller-Lisse |
|
|
Role of PET/CT in managing orbital disease A. Klingenstein |
|
| 10:20 – 11:00 | Coffee break |
| 11:00 – 14:30 | Orbital lesions I |
|
The problems of how to treat adenoid cystic carcinoma: why we should generally avoid exenteration G. Rose |
|
|
Update on capillary hemangiomas L. Baldeschi |
|
|
Surgical treatment of orbital vascular anomalies M. Sales Sanz |
|
|
Update on orbital meningioma treatment C. Schichor |
|
|
VEXAS Syndrome M. Sales Sanz |
|
|
Orbital metastases R. Allen |
|
| 12:30 – 13:30 | Lunch break |
|
A rationale approach to orbital surgery, routes to different orbital compartments L. Baldeschi |
|
|
Endonasal orbital approaches: Options and risks F. Haubner |
|
|
Ophthalmology meets Maxillofacial Surgery: computer-assisted surgery S. Otto |
|
|
Use of 3D technology in Oculoplastic and Orbital surgery D. Briscoe |
|
| 14:30 – 16:30 | Socket |
|
Short introduction into socket issues C. Hintschich |
|
|
Orbital Implants after Enucleation/Evisceration – a German data base A. Schuh |
|
|
Adequate volume replacement – how we got it wrong in the past G. Rose |
|
|
Dermofat grafting: The Munich experience A. Schuh |
|
|
Relining of the whole socket – the „Chevron graft“ technique G. Rose |
|
|
Artificial eye: Critical review of different materials B. Zimmermann |
|
|
Use of temporalis muscle flap in an ophthalmic socket reconstruction M. Sales Sanz |
|
|
Artificial eye: 3-D-printing B. Zimmermann |
|
| 16:30 – 17:00 | Coffee break |
| 17:00 – 17:45 | Interactive workshop |
|
Analizing orbital imaging: Radiological differential diagnosis? U. Müller-Lisse & Panel |
|
| 8:30 – 12:00 | Thyroid Eye Disease |
|
Evaluation: what really counts A. Eckstein |
|
|
Risk factors for Graves´ Disease – an update R. Gärtner |
|
|
Results of PREGO III A. Schuh |
|
|
Diagnosing TED-CON: Are we missing something? A. Garip-Kübler |
|
|
Neurofilaments as a tool to detect Optic Neuropathy in TED patients D. Briscoe |
|
|
Latest news on OCT & OCT-Angio A. Garip-Kübler |
|
|
Targeted therapies – theory and practice A. Eckstein |
|
|
Treating TED in the US in the time of teprotumumab R. Allen |
|
| 10:30 – 11:00 | Coffee break |
|
Optimal decompression in Thyroid Orbitopathy D. Briscoe |
|
|
Orbital decompression: Tips and tricks L. Baldeschi |
|
|
Functional outcome ofter decompression surgery C. Hintschich |
|
| Q&A/discussion | |
| 12:00 – 13:00 | Lunch break |
| 13:00 – 14:20 | Orbital lesions II |
|
Typical benign and malignant tumors of childhood L. Baldeschi |
|
|
Pediatric orbital inflammation R. Allen |
|
|
Rare Soft Tissue Tumors of the Orbit D. Briscoe |
|
|
Solitary fibrous tumors: results of a monocenter study A. Eckstein |
|
|
New treatment strategies: Checkpoint Inhibitors V. Schmelter |
|
|
Side effects of molecularly targeted agents R. Allen |
|
|
IgG4 – what is it all about? G. Rose |
|
| 14:45 – 15:15 | Coffee break |
| 15:15 – 16:30 | Cases |
|
Tracing unknows „Sherlock Holmes & Dr. Watson“ G. Rose, U. Schaudig, U. Mueller-Lisse & colleagues |
|
| 16:30 | End of the symposium |